PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
Increased activity of PAI-1 is associated with increased risk of arterial thrombosis, such as with unexplained premature Myocardial Infarction. As an acute phase reactant, the activity is increased after an acute event. Studies suggest PAI-1 may be a prognostic marker in early stage breast cancer.
Parameter(s) covered : 1
Report Frequency: Sample should reach NRL by or before 10th of the same month. Report in 2-3 weeks
Special Instruction: Duly filled Test Send Out Consent Form (Form 35) is mandatory.
Price : ₹ 11000.00
Parameters
- Send Out Comment